Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
- Publisher:
- SPRINGER JAPAN KK
- Publication Type:
- Journal Article
- Citation:
- Breast Cancer, 2023, 30, (3), pp. 466-477
- Issue Date:
- 2023-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Kou, K | |
dc.contributor.author | Cameron, J | |
dc.contributor.author | Youl, P | |
dc.contributor.author | Pyke, C | |
dc.contributor.author |
Chambers, S |
|
dc.contributor.author | Dunn, J | |
dc.contributor.author | Aitken, JF | |
dc.contributor.author | Baade, PD | |
dc.date.accessioned | 2024-01-17T03:26:13Z | |
dc.date.available | 2023-02-15 | |
dc.date.available | 2024-01-17T03:26:13Z | |
dc.date.issued | 2023-05 | |
dc.identifier.citation | Breast Cancer, 2023, 30, (3), pp. 466-477 | |
dc.identifier.issn | 1340-6868 | |
dc.identifier.issn | 1880-4233 | |
dc.identifier.uri | http://hdl.handle.net/10453/174690 | |
dc.description.abstract | BACKGROUND: Interval breast cancers (BC) are those diagnosed within 24 months of a negative mammogram. This study estimates the odds of being diagnosed with high-severity BC among screen-detected, interval, and other symptom-detected BC (no screening history within 2 years); and explores factors associated with being diagnosed with interval BC. METHODS: Telephone interviews and self-administered questionnaires were conducted among women (n = 3,326) diagnosed with BC in 2010-2013 in Queensland. Respondents were categorised into screen-detected, interval, and other symptom-detected BCs. Data were analysed using logistic regressions with multiple imputation. RESULTS: Compared with screen-detected BC, interval BC had higher odds of late-stage (OR = 3.50, 2.9-4.3), high-grade (OR = 2.36, 1.9-2.9) and triple-negative cancers (OR = 2.55, 1.9-3.5). Compared with other symptom-detected BC, interval BC had lower odds of late stage (OR = 0.75, 0.6-0.9), but higher odds of triple-negative cancers (OR = 1.68, 1.2-2.3). Among women who had a negative mammogram (n = 2,145), 69.8% were diagnosed at their next mammogram, while 30.2% were diagnosed with an interval cancer. Those with an interval cancer were more likely to have healthy weight (OR = 1.37, 1.1-1.7), received hormone replacement therapy (2-10 years: OR = 1.33, 1.0-1.7; > 10 years: OR = 1.55, 1.1-2.2), conducted monthly breast self-examinations (BSE) (OR = 1.66, 1.2-2.3) and had previous mammogram in a public facility (OR = 1.52, 1.2-2.0). CONCLUSION: These results highlight the benefits of screening even among those with an interval cancer. Women-conducted BSE were more likely to have interval BC which may reflect their increased ability to notice symptoms between screening intervals. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | SPRINGER JAPAN KK | |
dc.relation.ispartof | Breast Cancer | |
dc.relation.isbasedon | 10.1007/s12282-023-01439-4 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1112 Oncology and Carcinogenesis | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.classification | 3211 Oncology and carcinogenesis | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Queensland | |
dc.subject.mesh | Breast | |
dc.subject.mesh | Mammography | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Mass Screening | |
dc.subject.mesh | Early Detection of Cancer | |
dc.subject.mesh | Breast | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Mammography | |
dc.subject.mesh | Mass Screening | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Queensland | |
dc.subject.mesh | Female | |
dc.subject.mesh | Early Detection of Cancer | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Queensland | |
dc.subject.mesh | Breast | |
dc.subject.mesh | Mammography | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Mass Screening | |
dc.subject.mesh | Early Detection of Cancer | |
dc.title | Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study. | |
dc.type | Journal Article | |
utslib.citation.volume | 30 | |
utslib.location.activity | Japan | |
utslib.for | 1112 Oncology and Carcinogenesis | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2024-01-17T03:26:10Z | |
pubs.issue | 3 | |
pubs.publication-status | Published | |
pubs.volume | 30 | |
utslib.citation.issue | 3 |
Abstract:
BACKGROUND: Interval breast cancers (BC) are those diagnosed within 24 months of a negative mammogram. This study estimates the odds of being diagnosed with high-severity BC among screen-detected, interval, and other symptom-detected BC (no screening history within 2 years); and explores factors associated with being diagnosed with interval BC. METHODS: Telephone interviews and self-administered questionnaires were conducted among women (n = 3,326) diagnosed with BC in 2010-2013 in Queensland. Respondents were categorised into screen-detected, interval, and other symptom-detected BCs. Data were analysed using logistic regressions with multiple imputation. RESULTS: Compared with screen-detected BC, interval BC had higher odds of late-stage (OR = 3.50, 2.9-4.3), high-grade (OR = 2.36, 1.9-2.9) and triple-negative cancers (OR = 2.55, 1.9-3.5). Compared with other symptom-detected BC, interval BC had lower odds of late stage (OR = 0.75, 0.6-0.9), but higher odds of triple-negative cancers (OR = 1.68, 1.2-2.3). Among women who had a negative mammogram (n = 2,145), 69.8% were diagnosed at their next mammogram, while 30.2% were diagnosed with an interval cancer. Those with an interval cancer were more likely to have healthy weight (OR = 1.37, 1.1-1.7), received hormone replacement therapy (2-10 years: OR = 1.33, 1.0-1.7; > 10 years: OR = 1.55, 1.1-2.2), conducted monthly breast self-examinations (BSE) (OR = 1.66, 1.2-2.3) and had previous mammogram in a public facility (OR = 1.52, 1.2-2.0). CONCLUSION: These results highlight the benefits of screening even among those with an interval cancer. Women-conducted BSE were more likely to have interval BC which may reflect their increased ability to notice symptoms between screening intervals.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph